Antidiabetic action of nateglinide includes augmentation of glucagon-like peptide-1 activity mediated partly through inhibition of DPP IV mediated degradation

A.M. McKillop, N.A. Duffy, Brian Green, N. Irwin, V.A. Gault, F.P.M. O'Harte, P.R. Flatt

Research output: Contribution to journalMeeting abstractpeer-review

Original languageEnglish
Pages (from-to)S364-S364
Number of pages1
Issue numberS1
Publication statusPublished - 2007

Cite this